Want to see AQB full AI Analyst Report?
AQB Stock Chart & Stats
$0.96
-$0.09(-10.49%)
At close: 4:00 PM EST
$0.96
-$0.09(-10.49%)
Day’s Range― - ―
52-Week Range$0.70 - $2.95
Previous CloseN/A
Volume79.08K
Average Volume (3M)1.58M
Market Cap
$5.30M
Enterprise Value$7.32M
Total Cash (Recent Filing)$440.68K
Total Debt (Recent Filing)$3.80M
Price to Earnings (P/E)―
Beta0.77
Next Earnings
Aug 11, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-5.13
Shares Outstanding5,147,204
10 Day Avg. Volume221,557
30 Day Avg. Volume1,577,744
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)-1.91
Price to Sales (P/S)0.00
P/FCF Ratio>-0.01
Enterprise Value/Market Cap1.38
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda-2.31
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-7.28
Revenue Forecast (FY)$500.00K
Bulls Say, Bears Say
Bulls Say
Genetic Growth AdvantageFaster-growing AquAdvantage salmon shortens production cycles and can raise throughput per facility, lowering unit capital and operating cost per pound if biological performance and regulatory compliance hold. This structural productivity advantage supports scalability and margin improvement over time.
Land-based RAS ProductionOnshore RAS provides biosecurity, disease control, and geographic flexibility versus open-net pens, enabling consistent year-round supply to premium markets. These controlled systems support predictable yields and customer acceptance, forming a durable operational differentiation for scaling production responsibly.
Debt Reduction Via Preferred ExchangeConverting senior note principal and interest into preferred equity reduces near-term cash interest and reported debt, easing immediate leverage pressure. This improves short-term solvency and gives management time to stabilize operations and ramp production before seeking permanent capital solutions.
Bears Say
Persistent Cash BurnSustained negative operating and free cash flow forces ongoing reliance on external financing to fund working capital and operations. Over the medium term this limits the firm's ability to reinvest, delays capacity scaling, and raises execution risk if capital access tightens or terms worsen.
Negative Stockholders' EquityDeep accumulated losses and negative equity materially weaken financial flexibility, heighten covenant and solvency risk, and reduce creditor and investor confidence. This structural balance-sheet erosion constrains strategic options and increases the chance of further dilutive or expensive financing.
Reliance On Dilutive FinancingsFrequent private placements and convertible preferred issuances that convert into millions of shares create recurring dilution risk, undermining per-share economics. Long-term reliance on accredited-investor financings signals limited non-dilutive cash generation and raises governance and ownership concentration concerns.
AquaBounty Technologies News
AQB FAQ
What was AquaBounty Technologies Inc’s price range in the past 12 months?
AquaBounty Technologies Inc lowest stock price was $0.70 and its highest was $2.95 in the past 12 months.
What is AquaBounty Technologies Inc’s market cap?
AquaBounty Technologies Inc’s market cap is $5.30M.
When is AquaBounty Technologies Inc’s upcoming earnings report date?
AquaBounty Technologies Inc’s upcoming earnings report date is Aug 11, 2026 which is in 36 days.
How were AquaBounty Technologies Inc’s earnings last quarter?
AquaBounty Technologies Inc released its earnings results on Apr 30, 2026. The company reported -$0.263 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.263.
Is AquaBounty Technologies Inc overvalued?
According to Wall Street analysts AquaBounty Technologies Inc’s price is currently Overvalued.
Does AquaBounty Technologies Inc pay dividends?
AquaBounty Technologies Inc does not currently pay dividends.
What is AquaBounty Technologies Inc’s EPS estimate?
AquaBounty Technologies Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does AquaBounty Technologies Inc have?
AquaBounty Technologies Inc has 5,147,204 shares outstanding.
What happened to AquaBounty Technologies Inc’s price movement after its last earnings report?
AquaBounty Technologies Inc reported an EPS of -$0.263 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 0.644%.
Which hedge fund is a major shareholder of AquaBounty Technologies Inc?
Currently, no hedge funds are holding shares in AQB
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
AquaBounty Technologies Inc
AquaBounty Technologies, Inc. is a biotechnology firm dedicated to boosting productivity within the commercial fish farming sector across the United States and Canada. The company's research initiatives delve into genetics, genomics, fish health, and nutrition. Its flagship offering is AquAdvantage Salmon, a genetically engineered Atlantic salmon intended for human consumption. Beyond this, AquaBounty also supplies conventional Atlantic salmon, along with salmon eggs, juvenile fish (fry), and various byproducts. Established in 1991, the firm maintains its headquarters in Maynard, Massachusetts. It operated under the name Aqua Bounty Farms, Inc. until its rebranding in June 2004.
Technical Analysis
Ownership Overview
―
Insiders
1.30% Mutual Funds
1.73% Other Institutional Investors
96.51% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---